Effects of linagliptin monotherapy compared with voglibose on postprandial lipid profiles in Japanese patients with type 2 diabetes: linagliptin study of effects on postprandial blood glucose (L-STEP) sub-study 1.

Kurozumi, Akira; Okada, Yosuke; Satoh, Hiroaki; Inoue, Ikuo; Chimori, Hiroko; Akita, Etsuko; Shiraiwa, Toshihiko; Fujitani, Yoshio; Mita, Tomoya; Gosho, Masahiko; Watada, Hirotaka

Kurozumi, Akira; Okada, Yosuke; Satoh, Hiroaki; Inoue, Ikuo; Chimori, Hiroko; Akita, Etsuko; Shiraiwa, Toshihiko; Fujitani, Yoshio; Mita, Tomoya; Gosho, Masahiko; Watada, Hirotaka.

Afiliação

Kurozumi A; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Okada Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
Satoh H; Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Inoue I; Division of Diabetes and Endocrinology, Saitama Medical University, Saitama, Japan.
Chimori H; Chimori Medical Clinic, Osaka, Japan.
Akita E; Toyonaka Wakabakai Hospital, Osaka, Japan.
Shiraiwa T; Shiraiwa Medical Clinic, Osaka, Japan.
Fujitani Y; Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Mita T; Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Gosho M; Department of Clinical Trial and Clinical Epidemiology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
Watada H; Department of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Endocr J ; 65(4): 415-425, 2018 Apr 26.

Article em En | MEDLINE | ID: mdl-29367471

Assuntos

Glicemia/metabolismo; Diabetes Mellitus Tipo 2/tratamento farmacológico; Inibidores da Dipeptidil Peptidase IV/uso terapêutico; Hipoglicemiantes/uso terapêutico; Inositol/análogos & derivados; Linagliptina/uso terapêutico; Lipídeos/sangue; Período Pós-Prandial/efeitos dos fármacos; Idoso; Diabetes Mellitus Tipo 2/sangue; Inibidores da Dipeptidil Peptidase IV/farmacologia; Feminino; Humanos; Hipoglicemiantes/farmacologia; Inositol/farmacologia; Inositol/uso terapêutico; Linagliptina/farmacologia; Masculino; Pessoa de Meia-Idade; Período Pós-Prandial/fisiologia; Resultado do Tratamento

Palavras-chave

Dipeptidyl peptidase-4 inhibitor; Postprandial dyslipidemia; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google